Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.642, 2011-01, pp. : 2-2
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Pioglitazone the answer to managing type 2 DM in Europe?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 343, 2001-01 ,pp. :
Access to resources
Recommend
Pioglitazone the answer to managing type 2 diabetes in Europe?
Inpharma, Vol. 1, Iss. 1322, 2002-01 ,pp. :
Rosiglitazone and MI risk - will we ever know the answer?
Inpharma, Vol. 1, Iss. 1594, 2007-01 ,pp. :
Essential drugs concept the answer to rising costs in the West?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 467, 2004-01 ,pp. :
Quantifying Adverse Drug Events: Are Systematic Reviews the Answer?
By Mahyar Etminan Bruce Carleton Paula A. Rochon
Drug Safety, Vol. 27, Iss. 11, 2004-01 ,pp. :